On the other hand, NKG2D/NKG2D-ligand expression and function may inappropriately be associated with distressed organs or cells in autoimmune disease, suggesting that their blockade would be an important means of resolving inflammation consistent with their current evaluation in clinical trials in inflammatory bowel disease (49). This evidence concerns the gene KLRK1 and inflammatory bowel disease.